Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2000-07-13
2009-11-17
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S234100, C424S249100, C424S185100, C424S250100, C514S002600, C530S300000, C530S350000, C530S825000, C530S328000
Reexamination Certificate
active
07618636
ABSTRACT:
WO99/36544 discloses a large number of proteins fromNeisseria Meningitidis. The present invention relates to fragments of those proteins which comprise at least one antigenic determinant. Homologous sequences and proteins comprising these fragments are also disclosed.
REFERENCES:
patent: 7029845 (2006-04-01), Nassif et al.
patent: WO 90/06696 (1990-06-01), None
patent: WO-98/02547 (1998-01-01), None
patent: WO 99/36544 (1999-07-01), None
Relf et al. J. Clin. Microbiol. 30: 3190-3194, 1992.
Burgess et al. J. Cell Biol. 111: 2129-2138, 1990.
Bowie et al. Science 247: 1306-1310, 1990.
Lazar et al. Mol. Cellualr Biol. 8: 1247-1252, 1988.
McGuinnes et al. Mol. Microbiol. 7 (4): 505-514, 1993.
McGuinnes et al. Lancet 337: 514-517, 1991.
Rudinger et al. In: Peptide Hormones. (Ed) JA Parsons, University Park Press, Jun. 1976.
Houghten et al. Vaccines86. Cold Spring Harbor Laboratory, pp. 21-25, 1986.
Glick DM. Glossary of Biochemistry and Molecular Biology. Revised Edition, Portland Press, London, p. 75, 1997.
Cruse et al. Illustrated Dictionary of Immunology. p. 18, 1997.
Herbert et al. The Dictionary of Immunology, Academic Press, 3rd Edition, London, pp. 58 and 59, 1985.
Malorny et al. J. Bacteriol. 180: 1323-1330, 1998.
Gomez et al. Vaccine 14: 1340-1346, 1996, abstract.
Teerlink et al. J. Exp. Med. 166: 63-76, 1987, abstract.
Forest et al. Gene 192: 165-169, 1997, abstract.
Ala'Aldeen et al. Vaccine 12: 535-541, 1994.
Cruse et al. Illustrated Dictionary of Immunology, 2nd Edn., CRC Press, 2003.
McGuiness et al. Mol. Microbiol. 7:505-514, Feb. 1993.
Ala'Aldeen et al. (1996) “The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains,”Vaccine, 14(1):49-53.
Biegel Carson et al. (1999) “Ferric enterobactin binding and utilization byNeisseria gonorrhoeae”, Journal of Bacteriology, 181(9): 2895-2901.
Christodoulides et al. (1994) “Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bacterial antibodies against group BNeisseria meningitidis”, Microbiology, 140(11): 2951-2960.
Delvig et al. (1996) “Immune responses to linear epitopes on the porB protein ofNeisseria meningitidisin patients with systemic meningococcal disease”,Microbiology, 142(9): 2491-2498.
Poolman et al. (1995) “Development of a Meningococcal Vaccine,”Infect. Agents and Dis., 4: 13-28.
Rokbi et al. (1995) “Variable sequences in a mosaic-like domain of meningococcal tbp2 encode immunoreactive epitopes”,FEMS Microbiology Letters, 132: 277-283.
Tinsley et al. (Oct. 1996). “Analysis of the genetic differences betweenNeisseria meningitidisandNeisseria gonorrhoeae: Two closely related bacteria expressing two different pathogenicities,”Proccedings of the National Academy of Science, USA, 93(20):11109-11114.
EMBL Accession No. U56741, last updated Oct. 22, 1996, located at <http://www.ebi.ac.uk/cgi-bin/dbfetch?db=embl&id=U56741&style=raw> visted on Aug. 15, 2008. 2 pages.
European Examination Report mailed Mar. 16, 2004, for EP Application No. 00944161.9 filed Jan. 29, 2002, 9 pages.
European Examination Report mailed Apr. 5, 2005, for EP Application No. 00944161.9 filed Jan. 29, 2002, 9 pages.
Galeotti Cesira L.
Masignani Vega
Mora Marirosa
Scarlato Vincenzo
Scarselli Maria
Corman Robert
Devi S.
Hessler Amy
Lee Helen
Novartis Vaccines And Diagnostics SRL
LandOfFree
Antigenic meningococcal peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic meningococcal peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic meningococcal peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4088988